Generation Bio (GBIO) EBIT Margin (2023 - 2025)
Historic EBIT Margin for Generation Bio (GBIO) over the last 3 years, with Q3 2025 value amounting to 420.83%.
- Generation Bio's EBIT Margin fell 1840800.0% to 420.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 589.12%, marking a year-over-year increase of 2571200.0%. This contributed to the annual value of 715.82% for FY2024, which is 16311200.0% up from last year.
- Generation Bio's EBIT Margin amounted to 420.83% in Q3 2025, which was down 1840800.0% from 2995.56% recorded in Q2 2025.
- In the past 5 years, Generation Bio's EBIT Margin ranged from a high of 236.75% in Q3 2024 and a low of 3854.43% during Q2 2023
- For the 3-year period, Generation Bio's EBIT Margin averaged around 1366.21%, with its median value being 952.38% (2023).
- As far as peak fluctuations go, Generation Bio's EBIT Margin surged by 32846700bps in 2024, and later tumbled by -24257900bps in 2025.
- Quarter analysis of 3 years shows Generation Bio's EBIT Margin stood at 1334.99% in 2023, then skyrocketed by 58bps to 562.63% in 2024, then increased by 25bps to 420.83% in 2025.
- Its EBIT Margin stands at 420.83% for Q3 2025, versus 2995.56% for Q2 2025 and 313.32% for Q1 2025.